Oncternal Therapeutics Logo

Oncternal Therapeutics

Home - Oncternal Therapeutics

Who is Oncternal Therapeutics?

Oncternal Therapeutics is a clinical-stage oncology company developing a diverse pipeline of treatments to treat hematological malignancies and prostate cancer across multiple modalities. Based in San Diego, Oncternal is committed to advancing its pipeline rapidly and efficiently to bring patients a new wave of first-in-class cancer treatments. We are committed to advancing novel oncology therapies for the treatment of patients with cancers that have critical unmet medical need.

Encinitas, United States

11-50 Employees

Founding year: 2013



Products & services of Oncternal Therapeutics

Product An Overview of Next-Generation Androgen Receptor-Targeted Therapeutics in Development for the Treatment of Prostate Cancer, (Michael L Mohler, Arunima Sikdar, Suriyan Ponnusamy, Dong-Jin Hwang, Yali He, Duane D Miller, Ramesh Narayanan, Int J Mol Sci. 2021 Feb 20;22(4):2124) - Oncternal Therapeutics image
Service

Verified

An Overview of Next-Generation Androgen Receptor-Targeted Therapeutics in Development for the Treatment of Prostate Cancer, (Michael L Mohler, Arunima Sikdar, Suriyan Ponnusamy, Dong-Jin Hwang, Yali He, Duane D Miller, Ramesh Narayanan, Int J Mol Sci. 2021 Feb 20;22(4):2124) - Oncternal Therapeutics

An Overview of Next-Generation Androgen Receptor-Targeted Therapeutics in Development for the Treatment of Prostate Cancer, (Michael L Mohler, Arunima Sikdar, Suriyan Ponnusamy, Dong-Jin Hwang, Yali He, Duane D Miller, Ramesh Narayanan, Int J Mol Sci. 2021 Feb 20;22(4):2124)

View all products


Keywords

Therapeutics
Biotechnology
Health Diagnostics
Health Care

Industries

Biotechnology

Contact of Oncternal Therapeutics

City: Encinitas

State: California

Country: United States



Frequently asked questions (FAQ) about Oncternal Therapeutics

The company Oncternal Therapeutics is located in Encinitas, California, United States. It's worth noting that the company may has more corporate locations

As of the latest available information Oncternal Therapeutics has around 11-50 employees worldwide.

Oncternal Therapeutics was founded in 2013

The company Oncternal Therapeutics has it's main focus in the industries of Biotechnology

Competitors of Oncternal Therapeutics

Oncotelic Logo

Oncotelic

United States

View

Global Source Ventures LLC Logo

Global Source Ventures LLC

United States

1-10 Employees

View

OncoTherics Logo

OncoTherics

Poland

1-10 Employees

2009

View

OnKure Logo

OnKure

United States

1-10 Employees

2011

View

Exinda Therapeutics, LLC Logo

Exinda Therapeutics, LLC

United States

1-10 Employees

2013

View

ONCOtherapeutics Logo

ONCOtherapeutics

United States

11-50 Employees

2007

View

Onconova Therapeutics Logo

Onconova Therapeutics

United States

11-50 Employees

1998

View

OncoOne Logo

OncoOne

Austria

1-10 Employees

2018

View


Suitable topics for Oncternal Therapeutics

Topics which have been searched by others and may be interesting for you: